Long‐term protection of obese Zucker rat kidneys from fibrosis and renal failure with an angiotensin‐converting enzyme inhibitor/diuretic combination
暂无分享,去创建一个
G. Plante | C. Mandet | M. Bélair | I. Myara | O. Michel | J. Chevalier | Isabelle M Renaud | A. Chainey | Isabelle M. Renaud | Isabelle M. Renaud
[1] R. Glassock. Secondary minimal change disease. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] L. Ruilope,et al. Effect of Low-Dose Perindopril/Indapamide on Albuminuria in Diabetes: Preterax in Albuminuria Regression: PREMIER , 2003, Hypertension.
[3] P. Pagano,et al. Cardiovascular protective role of a low-dose antihypertensive combination in obese Zucker rats , 2003, Journal of hypertension.
[4] W. Keane,et al. Identification of persons at high risk for kidney disease via targeted screening: the NKF Kidney Early Evaluation Program. , 2003, Kidney international. Supplement.
[5] J. Schanstra,et al. In vivo bradykinin B2 receptor activation reduces renal fibrosis. , 2002, The Journal of clinical investigation.
[6] M. Praga. Obesity--a neglected culprit in renal disease. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[7] S. Laurent. Clinical benefit of very-low-dose perindopril-indapamide combination in hypertension. , 2001, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.
[8] G. Remuzzi,et al. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. , 2001, Journal of the American Society of Nephrology : JASN.
[9] D. Heudes,et al. Inflammation is probably not a prerequisite for renal interstitial fibrosis in normoglycemic obese rats. , 2001, American journal of physiology. Renal physiology.
[10] K. Denton,et al. Effects of angiotensin II on regional afferent and efferent arteriole dimensions and the glomerular pole. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.
[11] B. Brenner,et al. Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists. , 2000, Kidney international.
[12] J. Bariéty,et al. Oxidative stress occurs in absence of hyperglycaemia and inflammation in the onset of kidney lesions in normotensive obese rats. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] M. Safar,et al. Fixed low‐dose combination therapy in hypertension ‐ a dose response study of perindopril and indapamide , 2000, Journal of hypertension.
[14] P. Peeters,et al. Enalapril Increases Antioxidant Enzyme Activity in Renal Cortical Tissue of Five-Sixths- Nephrectomized Rats , 1998, Nephron.
[15] G. Wolf,et al. Molecular mechanisms of angiotensin II in the kidney: emerging role in the progression of renal disease: beyond haemodynamics. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] P. Mulder,et al. Fixed-dose combination of perindopril with indapamide in spontaneously hypertensive rats: haemodynamic, biological and structural effects , 1996, Journal of hypertension.
[17] D. Heudes,et al. Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model. , 1996, Journal of the American Society of Nephrology : JASN.
[18] R. Ames. A comparison of blood lipid and blood pressure responses during the treatment of systemic hypertension with indapamide and with thiazides. , 1996, The American journal of cardiology.
[19] D. Heudes,et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. I. Kidney structure and function. , 1994, The American journal of physiology.
[20] Y. Uehara,et al. Oxygen Radical Scavengers and Renal Protection by Indapamide Diuretic in Salt‐Induced Hypertension of Dahl Strain Rats , 1993, Journal of cardiovascular pharmacology.
[21] B. Kasiske,et al. The renin-angiotensin system in the type II diabetic obese Zucker rat. , 1993, Journal of the American Society of Nephrology : JASN.
[22] B. Kasiske,et al. The Obese Zucker Rat Model of Chronic, Progressive Glomerular Injury , 1993 .
[23] B. Kasiske,et al. Renal injury in obese Zucker rats: glomerular hemodynamic alterations and effects of enalapril. , 1992, The American journal of physiology.
[24] B. Kasiske,et al. Effects of genetic obesity on renal structure and function in the Zucker rat. , 1985, The Journal of laboratory and clinical medicine.
[25] W. Keane,et al. Relationship among altered glomerular barrier permselectivity, angiotensin II, and mesangial uptake of macromolecules. , 1985, Laboratory investigation; a journal of technical methods and pathology.
[26] N. Chen,et al. Cellular uptake of β2M and AGE‐β2M in synovial fibroblasts and macrophages , 2003 .
[27] F. Locatelli,et al. The renoprotective effect of combined antihypertensive drugs. , 2001, Journal of nephrology.
[28] M. Hurst,et al. Perindopril: an updated review of its use in hypertension. , 2001, Drugs.
[29] G. Brabant,et al. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes. , 2000, Kidney international.